Europe Gas Exchange Pulmonary Function Testing Market – Industry Trends and Forecast to 2028

  • Medical Devices
  • Published Report
  • Nov 2021
  • Europe
  • 350 Pages
  • No of Tables: 62
  • No of Figures: 37

Europe Gas Exchange Pulmonary Function Testing Market, By Test Type (Diffusion Capacity Test and Gas Distribution Test), System Type (Portable and Stationary), Application (Chronic Obstructive Pulmonary, Asthma, Chronic Shortness of Breath, Pulmonary Embolism, Pulmonary Hypertension Sarcoidosis, Interstitial Fibrosis, Restrictive Lung Disease, Lung Haemorrhage, and Others), End User (Hospitals, Specialty Clinics, Diagnostic Laboratories, and Others), Country (Germany, France U.K., Italy, Spain, Russia, Switzerland, Netherland, Turkey, Belgium and Rest of Europe) Industry Trends and Forecast to 2028

Europe Gas Exchange Pulmonary Function Testing Market Market Analysis and Insights : Europe Gas Exchange Pulmonary Function Testing Market

Europe gas exchange pulmonary function testing market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.5% in the forecast period of 2021 to 2028 and is expected to reach USD 240.69 million by 2028 from USD 137.92 million in 2020. The rising prevalence of pulmonary diseases in Europe and the growth of novel technological advancements for gas exchange pulmonary function testing are likely to be the major drivers which propel the demand of the market in the forecast period.

The gas exchange test, or in medical terms called lung diffusion testing, measures how well the lungs exchange gases. This is an important criterion of lung testing because the important role of the lungs is to allow oxygen to diffuse into the blood from the lungs and allow carbon dioxide to pass from the blood into the lungs. The pulmonary function test (PFT) is a non-invasive test that shows the lungs' performing capacity. The tests determine the lung volume, capacity, rates of flow, and gas exchange. The data collected can help the healthcare provider diagnose and adapt the treatment of certain lung diseases. In Europe, pulmonary and respiratory diseases rank second in mortality, incidence, prevalence, and costs. Lung cancer, asthma, and chronic obstructive pulmonary disease (COPD) are the main cause of respiratory causes of death in Western Europe and Central and Eastern Europe. The rise in prevalence of pulmonary diseases in Europe is due to a rise in pollution levels and inhalation of tobacco. Hence, this necessitates the use of gas exchange pulmonary function testing in Europe.

The factors expected to drive the Europe gas exchange pulmonary function testing market are the prevalence of pulmonology diseases in Europe and the technological developments in the gas exchange pulmonary function systems. However, the factors expected to restrain the market are the rise in the cost of the Europe gas exchange pulmonary function testing devices and the risks observed while using the pulmonary function testing devices. Moreover, non-invasive gas exchange pulmonary function test systems bolster the Europe gas exchange pulmonary function testing market growth. The rise in healthcare expenditure in Europe is expected to act as an opportunity for the market. The long-time product approval for gas exchange pulmonary function testing is expected to challenge the market.

The Europe gas exchange pulmonary function testing market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.  

Europe Gas Exchange Pulmonary Function Testing Market Europe Gas Exchange Pulmonary Function Testing Market Scope and Market Size

Europe gas exchange pulmonary function testing market is segmented based on test type, system type, application, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of test type, the Europe gas exchange pulmonary function testing market is segmented into diffusion capacity test and gas distribution test. In 2021, the diffusion capacity test segment is expected to dominate the Europe gas exchange pulmonary function testing market due to the presence of up-to-date diffusion capacity test type and instrumentation and reduced cost of production.
  • On the basis of system type, the Europe gas exchange pulmonary function testing market is segmented into portable and stationary. In 2021, the portable segment is expected to dominate the Europe gas exchange pulmonary function testing market due to ease of convenience, delivery of accurate results, and development of a quick treatment plan for the patient after observing the parameters.
  • On the basis of application, the Europe gas exchange pulmonary function testing market is segmented into chronic obstructive pulmonary, asthma, chronic shortness of breath, restrictive lung disease, interstitial fibrosis, lung hemorrhage, pulmonary embolism, pulmonary hypertension sarcoidosis, and others. In 2021, the chronic obstructive pulmonary disorder segment is expected to dominate the Europe gas exchange pulmonary function testing market due to the rise in pollution levels in the Europe region and diffusion capacity tests used to detect the chronic obstructive pulmonary disorder.
  • On the basis of end user, the Europe gas exchange pulmonary function testing market is segmented into hospitals, specialty clinics, diagnostics laboratories, and others. In 2021, the hospitals' segment is expected to dominate the Europe gas exchange pulmonary function testing market due to the presence of advanced diagnostic machinery for lung diagnosis, increased need for treatment for pulmonary diseases, and the presence of advanced diagnostic machinery for lung diagnosis are projected to dominate the market.

Europe Gas Exchange Pulmonary Function Testing Market Europe Gas Exchange Pulmonary Function Testing Market Country Level Analysis

The Europe gas exchange pulmonary function testing market is analyzed, and market size information is provided by test type, system type, application, and end user.

The countries covered in the Europe gas exchange pulmonary function testing market report are the U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, and Europe.

Europe is expected to grow with the CAGR in the forecasted periods and the growing R&D activities in the pulmonology segment. Germany is expected to dominate in the market in the European market. Germany is one of the leading countries due to the presence of major market players and increased technological advancements of the Europe gas exchange pulmonary function testing in the region.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of European brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.  

The Rise in Healthcare Expenditure for Europe Gas Exchange Pulmonary Function Testing in Emerging Countries in Europe and the Strategic Initiatives by Market Players are Creating New Opportunities in the Europe  Gas Exchange Pulmonary Function Testing Market

The Europe gas exchange pulmonary function testing market also provides you with detailed market analysis for every country growth in particular industry with Europe gas exchange pulmonary function testing sales, the impact of advancement in the Europe gas exchange pulmonary function testing particle, and changes in regulatory scenarios with their support for the Europe gas exchange pulmonary function testing particle market. The data is available for the historical period 2010 to 2019.

Competitive Landscape and Europe Gas Exchange Pulmonary Function Testing Market Share Analysis

Europe gas exchange pulmonary function testing market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points are only related to the company's focus on the Europe gas exchange pulmonary function testing market.

Some of the major companies in the Europe gas exchange pulmonary function testing market are VYAIRE, Geratherm Respiratory GmbH (A subsidiary of Geratherm), M.E.C. MEDICAL ELECTRONIC CONSTRUCTION, ECO MEDICS AG, PulmOne Advanced Medical Devices., Data Sciences International (A subsidiary of Harvard Bioscience), medical equipment europe GmbH, NDD Medical Technologies, MGC DIAGNOSTICS CORPORATION. (A subsidiary of ALTUS CAPITAL PARTNERS), SCHILLER, Medisoft Group, Biodex Medical Systems, Inc. (A subsidiary of MRI Technologies Inc), COSMED srl, PISTON MEDICAL, CARESTREAM MEDICAL, KoKo PFT, ASI Health Services, Swedish Health Services, Bellin Health Systems, among others.

Market players' strategic initiatives and new technological advancements for the Europe gas exchange pulmonary function testing market are bridging chronic wound treatment gaps. 

For instances,

  • In September 2020, Biodex Medical Systems Inc was acquired by Mirion Technologies. The acquisition would result in the portfolio of the Biodex Medical Systems Inc to merge with Mirion technologies product portfolio and to allow Mirion to extend its footprint in the medical field
  • In June 2021, the NDD Medical Technologies had improved and increased the product portfolio of gas exchange pulmonary function testing., such as EasyOne Air, Easy on-PC, EasyOne Pro, and EasyOne Pro LAB. The addition of products in the product range would result in a rise in net sales of the products, ease of availability, and a rise in customers from hospitals and diagnostic laboratories in Europe

Collaboration, joint ventures, and other strategies by the market player are enhancing the company market in the Europe gas exchange pulmonary function testing market, which also benefits the organization to improve their offering for treatment products.

Customization Available: Europe Gas Exchange Pulmonary Function Testing Market  

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market, and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.  


SKU-

TABLE 1 EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 2 EUROPE GAS DISTRIBUTION IN GAS EXCHAMNGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 3 EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY SYSTEM TYPE, 2019-2028 (USD MILLION)

TABLE 4 EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTINGMARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 5 EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTINGMARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 6 EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTING, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 7 EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 8 EUROPE GAS DISTRIBUTION IN GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 9 EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY SYSTEM TYPE, 2019-2028 (USD MILLION)

TABLE 10 EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 11 EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 12 GERMANY GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 13 GERMANY GAS DISTRIBUTION TEST IN GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 14 GERMANY GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY SYSTEM TYPE, 2019-2028 (USD MILLION)

TABLE 15 GERMANY GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 16 GERMANY GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 17 FRANCE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 18 FRANCE GAS DISTRIBUTION TEST IN GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 19 FRANCE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY SYSTEM TYPE, 2019-2028 (USD MILLION)

TABLE 20 FRANCE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 21 FRANCE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 22 U.K. GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 23 U.K. GAS DISTRIBUTION TEST IN GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 24 U.K. GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY SYSTEM TYPE, 2019-2028 (USD MILLION)

TABLE 25 U.K. GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 26 U.K. GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 27 ITALY GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 28 ITALY GAS DISTRIBUTION TEST IN GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 29 ITALY GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY SYSTEM TYPE, 2019-2028 (USD MILLION)

TABLE 30 ITALY GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 31 ITALY GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 32 SPAIN GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 33 SPAIN GAS DISTRIBUTION TEST IN GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 34 SPAIN GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY SYSTEM TYPE, 2019-2028 (USD MILLION)

TABLE 35 SPAIN GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 36 SPAIN GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 37 RUSSIA GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 38 RUSSIA GAS DISTRIBUTION TEST IN GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 39 RUSSIA GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY SYSTEM TYPE, 2019-2028 (USD MILLION)

TABLE 40 RUSSIA GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 41 RUSSIA GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 42 SWITZERLAND GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 43 SWITZERLAND GAS DISTRIBUTION TEST IN GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 44 SWITZERLAND GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY SYSTEM TYPE, 2019-2028 (USD MILLION)

TABLE 45 SWITZERLAND GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 46 SWITZERLANDGAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 47 NETHERLANDS GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 48 NETHERLANDS GAS DISTRIBUTION TEST IN GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 49 NETHERLANDS GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY SYSTEM TYPE, 2019-2028 (USD MILLION)

TABLE 50 NETHERLANDS GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 51 NETHERLANDS GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 52 TURKEY GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 53 TURKEY GAS DISTRIBUTION TEST IN GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 54 TURKEY GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY SYSTEM TYPE, 2019-2028 (USD MILLION)

TABLE 55 TURKEY GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 56 TURKEY GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 57 BELGIUM GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 58 BELGIUM GAS DISTRIBUTION TEST IN GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 59 BELGIUM GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY SYSTEM TYPE, 2019-2028 (USD MILLION)

TABLE 60 BELGIUM GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 61 BELGIUM GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 62 REST OF EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

Slides Slides Slides Slides Slides Slides